| SYK Snapshot | |
|---|---|
| Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. | |
| VALUATION DATA | |
| Market Capitalization | $92,315,959,296 | Price to Sales | 6.59 |
| Earnings per Share | $4.2000 |
| PE Ratio | 58.4262 |
| PRICE DATA | |
| Most Recent Close | $245.3900 |
| 52 Week High | $250.02 |
| 52 Week Low | $123.0139 |
| 50-Day Moving Average | $240.7526 |
| 200-Day Moving Average | $224.0226 |
| All data are from Alpha Vantage as of today. For more infomation on SYK see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search